Physicians at AdventHealth’s Central Florida Division are now administering the world’s first treatment to delay the onset of Type 1 Diabetes (T1D) as part of the TrialNet studies. TZIELD, or teplizumab-mzwv, is the first FDA-approved drug in the country to delay the onset of stage 3 T1D in adults, and patients who are eight years … Read more